A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...
Silo Pharma (NASDAQ: SILO) , a developmental-stage biopharmaceutical company, has filed a provisional patent application with the U.S. Patent and Tra ...
Results that may be inaccessible to you are currently showing.